Just caught wind of something pretty interesting happening in the neurotech space. Firefly Neuroscience has been making some serious moves with their brain imaging foundation model, and the market is clearly taking notice—stock just jumped 80% recently.

What caught my attention is the scale of what they're building. We're talking about a proprietary EEG/ERP database now sitting at over 191,000 brain scans, which they claim is the world's largest standardized repository. That's a massive data advantage if you're trying to train AI models on actual neuroscience data. They partnered with 99 commercial users throughout 2025 and processed more than 10,800 scans, which represents absolutely wild growth—partner sites up 1,880% year-over-year and clinical assessments up 3,227%.

What's particularly notable is how they're leveraging NVIDIA's GPU acceleration to power the next-generation processing. The company expanded its commercial footprint by over 20 times and saw a 33-fold increase in scan volumes. Firefly acquired Evoke Neuroscience and clearly integrated that into their broader strategy. Their FDA-cleared tech is positioned for depression, dementia, anxiety, concussions, ADHD diagnostics—basically the kind of clinical applications that have real market demand.

The CEO is pretty bullish on this being a critical step toward launching their foundation model. If they can actually deliver on the brain biomarker discovery angle, this could reshape how clinicians approach neurological diagnostics. AIFF was trading between $0.62 and $6.00 over the past year, and at $1.23 now with that 80% pop, there's clearly some momentum building.

Worth keeping an eye on how Firefly executes on the commercial launch. The data infrastructure they've built is the real asset here.